[1] |
HUANG DQ, TERRAULT NA, TACKE F, et al. Global epidemiology of cirrhosis—Aetiology, trends and predictions[J]. Nat Rev Gastroenterol Hepatol, 2023, 20: 388- 398. DOI: 10.1038/s41575-023-00759-2.
|
[2] |
DUAH A, DUAH F, AMPOFO-BOOBI D, et al. Acute kidney injury in patients with liver cirrhosis: Prevalence, predictors, and in-hospital mortality at a district hospital in Ghana[J]. Biomed Res Int, 2022, 2022: 4589767. DOI: 10.1155/2022/4589767.
|
[3] |
ALLAIRE M, MANFREDI S, LEROSEY L, et al. Screening and management of portal hypertension in advanced hepatocellular carcinoma: A French practice survey[J]. Clin Res Hepatol Gastroenterol, 2023, 47( 2): 102059. DOI: 10.1016/j.clinre.2022.102059.
|
[4] |
HUANG DQ, TAN DJH, NG CH, et al. Hepatocellular carcinoma incidence in alcohol-associated cirrhosis: Systematic review and meta-analysis[J]. Clin Gastroenterol Hepatol, 2023, 21( 5): 1169- 1177. DOI: 10.1016/j.cgh.2022.06.032.
|
[5] |
THABUT D, KUDO M. Treatment of portal hypertension in patients with HCC in the era of Baveno VII[J]. J Hepatol, 2023, 78( 3): 658- 662. DOI: 10.1016/j.jhep.2022.11.019.
|
[6] |
LIM J, KIM HI, KIM E, et al. Variceal bleeding is aggravated by portal venous invasion of hepatocellular carcinoma: A matched nested case-control study[J]. BMC Cancer, 2021, 21( 1): 11. DOI: 10.1186/s12885-020-07708-1.
|
[7] |
WU CWK, WONG GLH, WONG VWS, et al. Baveno VII criteria identify varices needing treatment in patients with hepatocellular carcinoma of different Barcelona Clinic Liver Cancer stages[J]. J Gastroenterol Hepatol, 2023, 38( 8): 1381- 1388. DOI: 10.1111/jgh.16218.
|
[8] |
YAO LQ, CHEN ZL, FENG ZH, et al. Clinical features of recurrence after hepatic resection for early-stage hepatocellular carcinoma and long-term survival outcomes of patients with recurrence: A multi-institutional analysis[J]. Ann Surg Oncol, 2022. DOI: 10.1245/s10434-022-11454-y.
|
[9] |
AKATEH C, BLACK SM, CONTEH L, et al. Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma[J]. World J Gastroenterol, 2019, 25( 28): 3704- 3721. DOI: 10.3748/wjg.v25.i28.3704.
|
[10] |
GRALNEK IM, CAMUS DUBOC M, GARCIA-PAGAN JC, et al. Endoscopic diagnosis and management of esophagogastric variceal hemorrhage: European society of gastrointestinal endoscopy(ESGE) guideline[J]. Endoscopy, 2022, 54( 11): 1094- 1120. DOI: 10.1055/a-1939-4887.
|
[11] |
LIU KY, ZHANG R, SHI CY, et al. Risk factors for emergency endoscopic variceal ligation treatment failure of acute variceal bleeding[J]. Scand J Gastroenterol, 2022, 57( 12): 1509- 1516. DOI: 10.1080/00365521.2022.2094719.
|
[12] |
GAO ZJ, ZHAO JR, LIU XF, et al. Portal vein thrombosis associated with high 14-day and 6-week rebleeding in patients after oesophageal variceal band ligation: A retrospective, multicentre, nested case-control study[J]. Hepatol Int, 2021, 15( 5): 1183- 1195. DOI: 10.1007/s12072-021-10224-4.
|
[13] |
STANLEY AJ, LAINE L. Management of acute upper gastrointestinal bleeding[J]. BMJ, 2019, 364: 1536. DOI: 10.1136/bmj.1536.
|
[14] |
National Health Commission of the People’s Republic of China. Standard for diagnosis and treatment of primary liver cancer(2024 edition)[J]. J Clin Hepatol, 2024, 40( 5): 893- 918. DOI: 10.12449/JCH240508.
中华人民共和国国家卫生健康委员会. 原发性肝癌诊疗指南(2024年版)[J]. 临床肝胆病杂志, 2024, 40( 5): 893- 918. DOI: 10.12449/JCH240508.
|
[15] |
SCHUPPAN D, AFDHAL NH. Liver cirrhosis[J]. Lancet, 2008, 371( 9615): 838- 851. DOI: 10.1016/S0140-6736(08)60383-9.
|
[16] |
GUINAZU C, FERNÁNDEZ MUÑOZ A, MALDONADO MD, et al. Assessing the predictive factors for bleeding in esophageal variceal disease: A systematic review[J]. Cureus, 2023, 15( 11): e48954. DOI: 10.7759/cureus.48954.
|
[17] |
TAPPER EB, FRIDERICI J, BORMAN ZA, et al. A multicenter evaluation of adherence to 4 major elements of the baveno guidelines and outcomes for patients with acute variceal hemorrhage[J]. J Clin Gastroenterol, 2018, 52( 2): 172- 177. DOI: 10.1097/MCG.0000000000000820.
|
[18] |
ZUCKERMAN MJ, ELHANAFI S, MENDOZA LADD A. Endoscopic treatment of esophageal varices[J]. Clin Liver Dis, 2022, 26( 1): 21- 37. DOI: 10.1016/j.cld.2021.08.003.
|
[19] |
LEE YR, PARK SY, TAK WY. Treatment outcomes and prognostic factors of acute variceal bleeding in patients with hepatocellular carcinoma[J]. Gut Liver, 2020, 14( 4): 500- 508. DOI: 10.5009/gnl19155.
|
[20] |
REDDY KR, MCLERRAN D, MARSH T, et al. Incidence and risk factors for hepatocellular carcinoma in cirrhosis: The multicenter hepatocellular carcinoma early detection strategy(HEDS) study[J]. Gastroenterology, 2023, 165( 4): 1053- 1063. e 6. DOI: 10.1053/j.gastro.2023.06.027.
|
[21] |
CARR BI, BAG HG, INCE V, et al. A combination of blood lymphocytes and AST levels distinguishes patients with small hepatocellular carcinomas from non-cancer patients[J]. J Gastrointest Cancer, 2021, 52( 4): 1211- 1216. DOI: 10.1007/s12029-021-00740-9.
|
[22] |
ZHANG WZ, XU XS, CAI LP, et al. Dysbiosis of the gut microbiome in elderly patients with hepatocellular carcinoma[J]. Sci Rep, 2023, 13: 7797. DOI: 10.1038/s41598-023-34765-w.
|
[23] |
SRINIVASA S, LEE WG, ALDAMEH A, et al. Spontaneous hepatic haemorrhage: A review of pathogenesis, aetiology and treatment[J]. HPB(Oxford), 2015, 17( 10): 872- 880. DOI: 10.1111/hpb.12474.
|
[24] |
ZHANG M, DING QH, BIAN CB, et al. Progress on the molecular mechanism of portal vein tumor thrombosis formation in hepatocellular carcinoma[J]. Exp Cell Res, 2023, 426( 1): 113563. DOI: 10.1016/j.yexcr.2023.113563.
|
[25] |
ZANETTO A, CAMPELLO E, SENZOLO M, et al. The evolving knowledge on primary hemostasis in patients with cirrhosis: A comprehensive review[J]. Hepatology, 2024, 79( 2): 460- 481. DOI: 10.1097/HEP.0000000000000349.
|
[26] |
ZANETTO A, CAMPELLO E, BURRA P, et al. Increased platelet ratio in patients with decompensated cirrhosis indicates a higher risk of portal vein thrombosis[J]. Liver Int, 2023, 43( 1): 155- 159. DOI: 10.1111/liv.15435.
|
[27] |
BALCAR L, MREKVA A, SCHEINER B, et al. Management of varices but not anticoagulation is associated with improved outcome in patients with HCC and macrovascular tumour invasion[J]. Cancer Imag, 2024, 24( 1): 9. DOI: 10.1186/s40644-024-00657-z.
|
[28] |
ALLAIRE M, RUDLER M, THABUT D. Portal hypertension and hepatocellular carcinoma: Des liaisons dangereuses[J]. Liver Int, 2021, 41( 8): 1734- 1743. DOI: 10.1111/liv.14977.
|
[29] |
CHEN CW, KUO CJ, LEE CW, et al. Albumin-bilirubin grade as a novel predictor of the development and short-term survival of post-banding ulcer bleeding following endoscopic variceal ligation in cirrhotic patients[J]. Medicina(Kaunas), 2022, 58( 12): 1836. DOI: 10.3390/medicina58121836.
|
[30] |
MAHMUD N, FRICKER Z, HUBBARD RA, et al. Risk prediction models for post-operative mortality in patients with cirrhosis[J]. Hepatology, 2021, 73( 1): 204- 218. DOI: 10.1002/hep.31558.
|
[31] |
LIU YB, CHEN MK. Epidemiology of liver cirrhosis and associated complications: Current knowledge and future directions[J]. World J Gastroenterol, 2022, 28( 41): 5910- 5930. DOI: 10.3748/wjg.v28.i41.5910.
|
[32] |
LIU Y, ZHENG JX, HAO JL, et al. Global burden of primary liver cancer by five etiologies and global prediction by 2035 based on global burden of disease study 2019[J]. Cancer Med, 2022, 11( 5): 1310- 1323. DOI: 10.1002/cam4.4551.
|